Meditative Neurofeedback for Depression

Last updated: March 24, 2025
Sponsor: University of California, San Diego
Overall Status: Active - Recruiting

Phase

N/A

Condition

Depression

Treatment

MediNF

Clinical Study ID

NCT06675240
MediNF
  • Ages > 18
  • All Genders

Study Summary

The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • moderate depression per PHQ9 symptom ratings

Exclusion

Exclusion Criteria:

  • active substance abuse/dependence

  • psychotic disorders

  • bipolar disorder

  • displaying acutely suicidal behaviors

Study Design

Total Participants: 27
Treatment Group(s): 1
Primary Treatment: MediNF
Phase:
Study Start date:
November 15, 2024
Estimated Completion Date:
June 15, 2026

Study Description

The goal of this open-label single-arm study is to test whether a 10-session meditative neurofeedback intervention significantly alleviates depressive symptons as well as improves secondary outcomes of rumination and mindfulness.

Connect with a study center

  • University of California San Diego

    La Jolla, California 92093
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.